Search hospitals > Hawaii > Honolulu

University of Hawaii Cancer Center

Claim this profile
Honolulu, Hawaii 96813
Global Leader in Parotid Gland Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Relapse
Conducts research for Cervical Adenocarcinoma
313 reported clinical trials
12 medical researchers
Photo of University of Hawaii Cancer Center in HonoluluPhoto of University of Hawaii Cancer Center in Honolulu

Summary

University of Hawaii Cancer Center is a medical facility located in Honolulu, Hawaii. This center is recognized for care of Parotid Gland Cancer, Cancer, Breast Cancer, Relapse, Cervical Adenocarcinoma and other specialties. University of Hawaii Cancer Center is involved with conducting 313 clinical trials across 501 conditions. There are 12 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.

Area of expertise

1Parotid Gland Cancer
Global Leader
University of Hawaii Cancer Center has run 96 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Cancer
Global Leader
University of Hawaii Cancer Center has run 60 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at University of Hawaii Cancer Center

Breast Cancer
Lung Cancer
Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Parotid Gland Cancer
Breast cancer
Small Cell Lung Cancer
Prostate Cancer
Rectal Cancer
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Hawaii Cancer Center?
Where is University of Hawaii Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Hawaii Cancer Center accept?
What awards or recognition has University of Hawaii Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security